| Financial Year |
March 31 2022 |
| Monetary Funds |
480,332,573.19 |
| Held-for-trading Financial Assets |
2,537,756,892.48 |
| Notes Receivable |
-- |
| Accounts Receivable |
807,748,135.39 |
| Advances to Suppliers |
3,352,603,310.30 |
| Other Receivables |
1,798,412,285.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
256,210,889.80 |
| Inventories |
166,053,974.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,256,064.22 |
| Total Current Assets |
9,146,292,795.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
253,562,981.60 |
| Investment Properties |
-- |
| Fixed Assetes |
474,254,476.94 |
| Under-construction Projects |
245,345.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,702,655.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
398,019.03 |
| Deferred Income Tax Assets |
72,288,723.32 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
842,428,707.80 |
| Total Assets |
9,988,721,503.36 |
| Short-Term Loans |
4,127,040,624.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
147,406,950.40 |
| Accounts Received In Advance |
6,448,190.87 |
| Employee Compensation Payable |
3,207,539.07 |
| Taxes Payable |
14,739,146.88 |
| Interest Payable |
1,302,990,640.35 |
| Dividend Payable |
5,501,144.30 |
| Other payables |
1,754,700,605.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,782,055.00 |
| Other Current Liabilities |
2,745,186,278.90 |
| Sub-Total of Current Liabilities |
8,809,917,692.26 |
| Long-term Loans |
417,540,289.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
569,212.77 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
313,162,742.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
737,043,074.66 |
| Total Liabilities |
9,546,960,766.92 |
| Paid-In Capital(Or Share Stock) |
1,158,258,350.00 |
| Capital Surplus |
2,057,961,361.99 |
| Surplus Reserve |
173,573,853.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,097,238,024.89 |
| Minority Stockholder's Interest |
391,403,347.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
50,357,388.59 |
| Owner's Equity（Stockholder's Equity） |
441,760,736.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,988,721,503.36 |
